Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.5900
+0.0240 (4.24%)
At close: Apr 1, 2025, 4:00 PM
0.5955
+0.0055 (0.94%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Harvard Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2692228115288167
Upgrade
Market Cap Growth
-59.70%-59.70%97.92%-59.89%72.07%44.02%
Upgrade
Enterprise Value
66133268167336218
Upgrade
Last Close Price
0.592.115.352.777.054.29
Upgrade
Forward PE
13.1117.5823.2617.8722.0316.19
Upgrade
PS Ratio
0.270.982.041.022.421.64
Upgrade
PB Ratio
0.411.453.131.603.452.18
Upgrade
P/FCF Ratio
-18.66-4294.2420.44
Upgrade
P/OCF Ratio
18.0663.9116.28100.17227.9817.92
Upgrade
PEG Ratio
1.031.031.031.031.031.03
Upgrade
EV/Sales Ratio
0.711.422.391.482.832.14
Upgrade
EV/EBITDA Ratio
27.2054.6428.2770.1529.7322.08
Upgrade
EV/EBIT Ratio
-107.55-91.1296.86
Upgrade
EV/FCF Ratio
-21.92-5018.2026.69
Upgrade
Debt / Equity Ratio
0.700.700.590.750.680.75
Upgrade
Debt / EBITDA Ratio
9.659.653.7012.094.244.79
Upgrade
Debt / FCF Ratio
--3.51-850.157.04
Upgrade
Asset Turnover
0.710.710.790.740.750.64
Upgrade
Inventory Turnover
1.641.641.791.892.061.99
Upgrade
Quick Ratio
0.350.350.770.911.171.24
Upgrade
Current Ratio
0.820.821.852.202.432.46
Upgrade
Return on Equity (ROE)
-18.19%-18.19%-4.70%-12.23%-0.36%-9.86%
Upgrade
Return on Assets (ROA)
-2.23%-2.23%1.10%-2.11%1.45%0.88%
Upgrade
Return on Capital (ROIC)
-2.63%-2.63%1.29%-2.43%1.68%1.00%
Upgrade
Return on Capital Employed (ROCE)
--2.30%-2.70%1.70%
Upgrade
Earnings Yield
-47.70%-13.48%-1.49%-8.25%-0.10%-4.67%
Upgrade
FCF Yield
-4.63%-1.31%5.36%-0.38%0.02%4.89%
Upgrade
Buyback Yield / Dilution
-2.64%-2.64%-2.43%-2.65%-4.41%-2.19%
Upgrade
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q